Vivani Medical Inc develops and commercializes drug and device implants that treat patients with chronic diseases with high unmet medical need. Vivani Medical Inc develops and commercializes drug and device implants that treat patients with chronic diseases with high unmet medical need.
Regulatory approval to initiate first-in-human study with a miniature, ultra long-acting GLP-1 (exenatide) implant in obese or overweight individuals in Australia Miniature, ultra long-acting...
Vivani Medical, Inc. (NASDAQ: VANI) (the “Company” or “Vivani”), an innovative biopharmaceutical company developing miniaturized, ultra long-acting drug implants, announced today that it will...
NPM-115 clinical program utilizes a miniature, GLP-1 (exenatide) implant designed to provide comparable efficacy to semaglutide, the active ingredient in Ozempic®/Wegovy®, with twice-yearly...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.1008 | -7.14488233626 | 1.4108 | 1.47 | 1.225 | 205547 | 1.34672044 | CS |
4 | 0.04 | 3.14960629921 | 1.27 | 1.47 | 1.21 | 126531 | 1.34413173 | CS |
12 | -0.01 | -0.757575757576 | 1.32 | 1.47 | 1.1 | 96616 | 1.26151159 | CS |
26 | -0.52 | -28.4153005464 | 1.83 | 2.09 | 1.1 | 219774 | 1.48453003 | CS |
52 | 0.35 | 36.4583333333 | 0.96 | 7.8 | 0.84 | 902646 | 3.34696582 | CS |
156 | -2.89 | -68.8095238095 | 4.2 | 7.8 | 0.7536 | 438492 | 3.20737768 | CS |
260 | -2.89 | -68.8095238095 | 4.2 | 7.8 | 0.7536 | 438492 | 3.20737768 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.